Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Participants With Mild Acne

NCT07013747 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
120
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi Pasteur, a Sanofi Company